Symrise AG (Holzminden, Germany) has signed a definitive agreement to sell AmeriTerpenes LLC (Jacksonville, Fla.), its terpene ingredients business, to international private equity investor Mutares SE & Co. KGaA (Munich, Germany). With this divestment, Symrise sharpens its portfolio and concentrates management attention on core growth platforms under the ONE Symrise strategy. The agreement supports customer continuity and positions AmeriTerpenes to further develop its renewable terpene ingredient portfolio for fragrance, flavor, and industrial applications under focused ownership.
Symrise Investor Tour Capital MarketDays 2019. Colonel’s Island, Georgia. Jacksonville, Florida. U.S.A. January 18, 2019 (source: Symrise)
AmeriTerpenes LLC, a leading producer of renewable terpene ingredients, serves customers across fragrance, flavor, and industrial applications from its U.S.-based manufacturing sites in Jacksonville, Florida, and Colonels Island, Georgia. Terpene ingredients play a key role in fragrance, flavor, and industrial formulations, where customers seek renewable, consistent, and high-performing ingredient solutions. With the successful operational carve-out completed over the past months, the business has positioned itself well to continue its development under new ownership.
The divestiture enables Symrise to further sharpen its portfolio and increase management focus on its core growth platforms, while supporting the company’s long-term ambition to deliver sustainable, profitable growth, operational excellence, and disciplined capital allocation under the ONE Symrise strategy.
Dr. Jean-Yves Parisot, CEO of Symrise, commented: “This transaction gives a good example of how we are actively shaping Symrise for the future with continued portfolio management: AmeriTerpenes is a strong business with excellent people, longstanding customer relationships, and differentiated manufacturing capabilities. We are pleased that, with Mutares, we have found an experienced owner that brings a strong operational track record in corporate carve-outs and is well-suited to support AmeriTerpenes into its future. We also look forward to continuing our partnership with AmeriTerpenes and Mutares as its new owner through strategic agreements entered into as part of the transaction.”
The acquisition of AmeriTerpenes represents a new platform investment for Mutares’ Chemicals & Materials segment and further strengthens the Group’s footprint in the strategically important U.S. market.
Johannes Laumann, CIO of Mutares, commented: “With this transaction, we are adding a strong platform to our Chemicals & Materials segment while further strengthening our presence in the U.S. market. As a corporate carve-out, the company offers exactly the type of special situation for which we have designed our investment approach. This deal marks the promise to deliver our strategy of strong growth in the segment and the U.S. market.”
Symrise and Mutares are committed to ensuring a seamless transition, maintaining business continuity, customer service excellence, and strong relationships with customers and suppliers. Following closing, Symrise and AmeriTerpenes will continue their long-standing commercial relationship. The agreed supply arrangements secure long-term access to renewable, terpene-based raw materials and create an enduring industrial partnership that supports both companies’ future growth plans.
The signing and closing of the transaction took place simultaneously. Both parties have agreed to keep financial details relating to the transaction confidential.
The transaction is expected to result in a non-cash disposal loss amounting to a mid-double-digit million-euro impact, which will be reflected in Symrise’s annual financial statements for 2026.
Stifel Financial Corp. (St. Louis, Mo.) acted as financial adviser, Alvarez & Marsal Holdings, LLC (New York, N.Y.) as carve-out and vendor due diligence adviser, and Troutman Pepper Locke LLP (Atlanta, Ga.) as legal adviser to Symrise.